Alicia K. Morgans, Tamim Niazi, Neal D. Shore, Jürgen E. Gschwend, Ashley Ross, Thomas A. Hope, Alex Chehrazi-Raffle, Stephane Supiot, Philippe Barthélémy, Andreas Røder, Andrea Juliana Gomes, Bernardo Herrera Imbroda, Matthieu Gratton, Carmen Belen Congregado Ruiz, Heikki Joensuu, Miryana Dimova-Dobreva, Marie-Aude Le Berre, Iris Kuss, Karim Fizazi. "Darolutamide plus androgen-deprivation therapy (ADT) in patients with high-risk biochemical recurrence (BCR) of prostate cancer: A phase 3, randomized, double-blind, placebo-controlled study (ARASTEP).." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.5_suppl.tps432